PackGene Biotech

Private

Houston, TexasHealthcare & Life Scienceshttps://www.packgene.com/

Last Round

Series C

Extension

Dec 1, 2023

Total Funding Raised

$59.29M

Company Overview

PackGene Biotech is a biotechnology company that provides comprehensive AAV vector, mRNA, plasmid DNA, and lentiviral vector solutions for early-stage drug discovery, preclinical development, and clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

viral vector manufacturinggene therapy CDMOAAV manufacturingcontract development and manufacturing organizationCDMOGMP manufacturingclinical trial supplyplasmid DNA productionlentivirus servicescontract research organizationCROmRNA servicesvector designAI-driven capsid designcapsid engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PackGene Biotech Comps

Public and private peers based on sector, stage, and business model.

PackGene Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PackGene Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C Extension	Dec 1, 2023
Series C	Apr 18, 2023
VC Round	Mar 1, 2021
Series B Extension	Oct 26, 2020
Series B	Aug 12, 2020
Series A	Feb 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

LiYing Yang

Chief Technology Officer

Executive Team

PackGene Biotech Investors

Notable investors and investment history

PackGene Biotech investors
Investor	Rounds
Cathay Capital	VC Round, Series B Extension, Series B
招银国际金融有限公司	VC Round
Kaitai Capital	VC Round
Guangzhou Industrial Investment Fund Management	VC Round
HongShan	VC Round, Series B Extension
Guangzhou Emerging Industry Development Fund Management Co., Ltd.	Series C
Guangzhou Development District Industry Fund Investment Group	Series C

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 4, 2025
Monthly visitors increased 33% MoM, reaching 7.1K.
May 2, 2025
Monthly visitors grew 281% MoM, reaching 6.1K.

View all signals

PackGene Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PackGene Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PackGene Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas

Employee Range50

Year Founded2014

Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.